1Stock1.com
Google
 
1Stock1 Home
Financial Ratios
Mutual Fund Investing Terms
Option Trading Terms 
Stock Investing Terms
PDL BioPharma, Inc. (PDLI) Yearly Returns
     Year
  Beginning Price
  Ending Price
  Gain or Loss
  Percent Gain or Loss
1993
11.875
24.25
12.375
104.21%
1994
24.25
15.75
-8.50
-35.05%
1995
15.75
23.125
7.375
46.83%
1996
23.125
36.50
13.375
57.84%
1997
36.50
40.00
3.50
9.59%
1998
40.00
23.125
-16.875
-42.19%
1999
23.125
70.00
46.875
202.70%
2000
70.00
173.75*
103.75
148.21%
2001
86.875
65.60*
-21.275
-24.49%
2002
32.80
8.50
-24.30
-74.09%
2003
8.50
17.90
9.40
110.59%
2004
17.90
20.66
2.76
15.42%
2005
20.66
28.42
7.76
37.56%
2006
28.42
20.14
-8.28
-29.13%
2007
20.14
17.52
-2.62
-13.01%
2008
17.52
6.18
-11.34
-64.73%
2009
6.18
6.86
0.68
11.00%
2010
6.86
6.23
-0.63
-9.18%
2011
6.23
6.20
-0.03
-0.48%
2012
6.20
7.04
0.84
13.55%
2013
7.04
8.44
1.40
19.89%
2014
8.44
7.71
-0.73
-8.65%
2015
7.71
3.54
-4.17
-54.09%
2016
3.54
2.12
-1.42
-40.11%
2017
2.12
2.74
0.62
29.25%
2018
2.74
2.90
0.16
5.84%
2019
2.90
3.245
0.345
11.90%
2020
3.245
3.88012*
0.63512
19.57%
*The 2000 ending price for PDL BioPharma has been adjusted for a 2 for 1 stock split.
*The 2001 ending price for PDL BioPharma has been adjusted for a 2 for 1 stock split.
*In 2020, PDL BioPharma completed its spinoff of LENSAR, Inc. (LNSR). PDLI shareholders received .075879 shares of LNSR for every share of PDLI held. In addition, PDLI entered a dissolution process, at the end of 2020 the shares were valued at $3.33 per share.
Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).
Disclaimer/Contact Us
Stock Performance Guide         
Yearly Stock Returns Index     
Back to Yearly Stock Returns Index
Articles
From
1stock1.com